CONMED Corp — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-03-01

Reporting Person: Hartman Curt R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	Common Stock	M	1950	—	Acquired	44454	Direct
2019-03-01	Common Stock	M	2250	—	Acquired	46704	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-01	Options To Purchase Common Stock	$78.76	A	200000	Acquired	2029-03-01	Common Stock (200000)	Direct
2019-03-01	Rsus (restricted Stock Units)	$0	M	1950	Disposed	2025-02-27	Common Stock (1950)	Direct
2019-03-01	Rsus (restricted Stock Units)	$0	M	2250	Disposed	2026-03-01	Common Stock (2250)	Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock Incentive Plan and generally vest in equal amounts (25%) over a four year period.

F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.